The largest database of trusted experimental protocols

9 protocols using rhfgf basic

1

Generating Down Syndrome iPSC-Derived NPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
We previously established iPSCs with HSA21 by transducing fibroblast cells from one male and one female (DS1 and DS2) with characteristic DS features and a full T21, as well as from two age and gender-matched healthy individuals (Ctrl1 and Ctrl2) [10 ]. Fibroblasts were reprogrammed using a non-integrating method with CytoTune™-iPS 2.0 Sendai Reprogramming Kit (ThermoFisher Scientific, cat no: A16517). Standard karyotype analysis confirmed T21 or euploidy in iPSC derived from DS patients and healthy donors, respectively. Selected iPSC lines were induced to neural progenitor cells (NPC) as described [10 ]. The NPCs were grown on 0.1 mg poly-L-ornithine (Sigma-Aldrich, cat no.: P4957-50ML) and 1 μg/mL laminin (Sigma-Aldrich, cat no: L2020-1MG)-coated plates in DMEM/F12 GlutaMAX medium (Gibco, cat no.: 31331028) supplemented with 10 ng/mL rhFGF-basic (R&D Systems, cat no.: 233-FB-010), 10 ng/mL rhEGF (R&D Systems, cat no.: 236-EG-200), B27 supplement (1:1000, Gibco, cat no.: 08-0085SA), N2 supplement (1:100, Gibco, cat no.: 17502-048), and 1% penicillin/streptomycin (Gibco, cat no.: 15140-122). Self-renewing NPCs derived from the four donors were differentiated for 30 days into DiffNPCs using an undirected protocol (Fig. 1) as described [10 , 24 ].
+ Open protocol
+ Expand
2

Establishing Cell Line Cultures for Cancer Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-231 expressing green fluorescent protein (GFP) was a generous gift from Weinberg lab17 (link). Normal breast fibroblast (NBF) and cancer-associated fibroblast (CAF) were provided by Orimo lab and previously described by Kojima et al.24 (link) MCF-7 and normal human dermal fibroblast (NHDF) were purchased from ATCC. For in vivo studies, MCF-7 cells were engineered to express firefly luciferase with a lentivirus containing luciferase reporter (MCF-7/Luc) following a previous report67 (link). Primary human bone marrow mesenchymal stromal/stem cells (BMSCs) were derived from whole human bone marrow aspirates (Lonza)68 (link). BMSCs were expanded in alpha-modified Minimum Essential Medium Eagle (alpha-MEM), 20 mg L−1 gentamycin, 10% FBS, 2.5 ug L−1 rhFGF-basic (R&D Systems), 100 U ml−1 penicillin, and 100 mg ml−1 streptomycin. All other cells and co-cultures were grown in Dulbecco’s MEM (DMEM) supplemented with 10% FBS, 100 U ml−1 penicillin and 100 μg ml−1 streptomycin.
+ Open protocol
+ Expand
3

Patient-Derived PDAC Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experiments with human material were performed in accordance with the Declaration of Helsinki and were approved by the ethics committee of the Medical Faculty of Heidelberg University (323/2004, Amendment 03). Informed consent was received from participants before study inclusion. Generation and cultivation of patient-derived PDAC cultures have been described previously (16 (link)). Cultures were subjected to SNP typing and Multiplex Cell Contamination Testing (Multiplexion). Cultures were grown in DMEM Advanced F12 medium supplemented with 0.6% (w/v) glucose, 2 mM L-glutamine, 2% B27 supplement (1×) (all Thermo Fisher Scientific), 12 μg/ml heparin and 5 mM HEPES buffer (both Sigma Aldrich), 10 ng/ml rhFGF basic, 20 ng/ml rhFGF-10, and 20 ng/ml rhNodal (all R&D Systems). Cytokines were renewed twice per week.
+ Open protocol
+ Expand
4

Exosome Isolation from iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Exosomes were extracted from iPSCs using total exosome isolation reagent (Thermo Fisher Scientific, Waltham, MA, USA) as per the manufacturer’s instructions. Briefly, iPSCs were cultured in 6-well plates, until 80% confluence, in serum-free iPSC growth medium containing Dulbecco’s modified eagle’s medium (DMEM)/Nutrient Mixture F-12 Ham 1:1 (Biological Industries, Beit Haemek, Israel) containing 20% KnockOut SR (Life Technologies, Waltham, MA, USA), 1% nonessential amino acid, 1% L-glutamine (Biological Industries, Beit Haemek, Israel), 0.2% 2-mercaptoethanol (Life Technologies, Waltham, MA, USA), and rhFGF basic (4 ng/mL) (R and D Systems, Minneapolis, MN, USA), at 37 °C, 95% air, and 5% CO2 in an incubator. Culture medium was then collected and centrifuged at 2000× g for 30 min. The supernatant was then transferred to a new tube and mixed well with 5 mL of total exosome isolation reagent. The homogenous solution was incubated at 4 °C overnight and then centrifuged at 4 °C at 10,000× g for 1 h. The supernatant was then aspirated, and the exosomes were suspended in 500 µL PBS and stored at −80 °C until use. Extracted exosomes were analyzed for particle visualization and rapid, automated analysis of size distribution and concentration by nanoparticle tracking system (NanoSight NS300, Weizmann institution, Rehovot, Israel). Exosomes were saved at −80 °C for following experiments.
+ Open protocol
+ Expand
5

Establishing Cell Line Cultures for Cancer Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-231 expressing green fluorescent protein (GFP) was a generous gift from Weinberg lab17 (link). Normal breast fibroblast (NBF) and cancer-associated fibroblast (CAF) were provided by Orimo lab and previously described by Kojima et al.24 (link) MCF-7 and normal human dermal fibroblast (NHDF) were purchased from ATCC. For in vivo studies, MCF-7 cells were engineered to express firefly luciferase with a lentivirus containing luciferase reporter (MCF-7/Luc) following a previous report67 (link). Primary human bone marrow mesenchymal stromal/stem cells (BMSCs) were derived from whole human bone marrow aspirates (Lonza)68 (link). BMSCs were expanded in alpha-modified Minimum Essential Medium Eagle (alpha-MEM), 20 mg L−1 gentamycin, 10% FBS, 2.5 ug L−1 rhFGF-basic (R&D Systems), 100 U ml−1 penicillin, and 100 mg ml−1 streptomycin. All other cells and co-cultures were grown in Dulbecco’s MEM (DMEM) supplemented with 10% FBS, 100 U ml−1 penicillin and 100 μg ml−1 streptomycin.
+ Open protocol
+ Expand
6

Alveolar Organoid Generation from hPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
First, hPSCs were induced to NKX2.1+ lung progenitors as described earlier (‘ALO differentiation’ section). The NKX2.1+ lung progenitors were then resuspended in growth factor reduced Matrigel (Corning) at a density of 100,000 cells ml−1 and pipetted (50 μl droplets) onto the base of tissue-culture plates. The three-dimensional culture was maintained in alveolar medium composed of cSFDM containing 250 ng ml−1 FGF2 (rhFGFbasic; R&D Systems), 100 ng ml−1 FGF10, 50 nM dexamethasone, 100 nM 8-bromoadenosine 3′,5′-cyclic monophosphate sodium salt (Millipore-Sigma), 100 nM 3-isobutyl-1-methylxan-thine (Millipore-Sigma) and 10 μM Y-27632 (Tocris).
+ Open protocol
+ Expand
7

Culturing Tumor-Derived Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Partially digested tumor minces were cultured in Advanced DMEM-F12 medium supplemented with 6 mg/mL d-Glucose, 2% B27-supplement (1×), 2 mM L-glutamine, 5 mM HEPES buffer and 6 μg/mL heparin sodium salt. Fibroblast growth factor (rhFGF-basic, 10 ng/mL, R&D Systems, Wiesbaden, Germany), rhFGF10 (20 ng/mL, R&D Systems, Wiesbaden, Germany) and rhNodal (20 ng/mL, R&D Systems, Wiesbaden, Germany) were added to the culture medium and renewed every 3–4 days. Medium was changed twice per week or when beginning to turn orange. When they reached 80–90% confluency, cells were detached by accutase (PAA) and split 1:1 to 1:10. Cultures were tested for authenticity and contamination, utilizing Multiplex Cell Line Authentication (MCA) and Cell Contamination Test Analyses (McCT; Multiplexion, Heidelberg, Germany).
+ Open protocol
+ Expand
8

Generation and Characterization of Patient-Derived Pancreatic Cancer Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patient-derived pancreatic cancer cultures PC9 and PC18 were generated and cultivated as described previously [22 ]. Cultures were subjected to SNP typing and Multiplex Cell Contamination Testing (Multiplexion, Heidelberg, Germany). PC9 and PC18 cultures were grown in DMEM Advanced F12 medium supplemented with 0.6% (w/v) glucose, 2 mM L-glutamine, 2% B27 supplement (1×) (all Thermo Fisher Scientific), 12 μg/mL heparin and 5 mM HEPES buffer (both Sigma Aldrich), referred to as CSCN medium. Cytokines, i.e., 10 ng/mL rhFGF-basic, 20 ng/mL rhFGF-10, and 20 ng/mL rhNodal (all R&D Systems) were added to the cultures and renewed twice a week.
+ Open protocol
+ Expand
9

Efficient Hematopoietic and Neural Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For hematopoietic differentiation, the StemDiff™ Hematopoietic Kit (Stem Cell Technologies) was used in accordance with the manufacturer’s instructions. For neural differentiation, iPSCs were dissociated into single cells using Accutase™ (Stem Cell Technologies), transferred at 2,000 cells/well into 96-multiwell ultra-low attachment (ULA) round-bottom plates (BD Falcon), and centrifuged for 5 min at 1,500 rpm for embryoid body formation. Next, neural induction was performed in three different types of media. Embryoid bodies were incubated for 3 days in Dulbecco’s modified Eagle medium (DMEM)/F12 (Thermo Fisher) supplemented with N2 (Themo Fisher), B27 (Thermo Fisher), 100 nM LDN193189 (Tocris) and 10 μM SB431542 (Tocris). Subsequently, 20 ng/ml rhFGF basic (R&D Systems) and 20 ng/ml rhEGF (R&D Systems) were added. After incubation for a few days, EBs were plated onto poly-L-ornithine (Sigma) and L-laminin (Thermo Fisher)-coated plates and then neural rosettes were manually collected and maintained in DMEM/F12 supplemented with N2, B27, 20 ng/ml rhFGF basic, 20 ng/ml rhEGF, and 3 μM CHIR99021 (Tocris).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!